Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunic Inc (NQ: IMUX ) 1.510 +0.020 (+1.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immunic Inc < Previous 1 2 3 4 5 6 Next > Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying May 23, 2024 While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying. Via InvestorPlace Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. Via TheNewswire.com Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day Via News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Immunic chief medical officer discusses promising treatments to mark World IBD Day Via News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. Via TheNewswire.com IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 May 08, 2024 IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Immunic's Earnings Outlook February 21, 2024 Via Benzinga Immunic: Q3 Earnings Insights November 14, 2023 Via Benzinga A Preview Of Immunic's Earnings November 13, 2023 Via Benzinga Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day Via News Direct Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease... Via TheNewswire.com Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones Via News Direct Topics Intellectual Property Exposures Intellectual Property Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered,... Via TheNewswire.com Topics Intellectual Property Exposures Intellectual Property Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal Via News Direct Immunic "super excited" about latest PMS trial data October 11, 2023 --News Direct-- Via News Direct Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in... Via TheNewswire.com Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 --News Direct-- Via News Direct Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month,... Via TheNewswire.com Immunic And 2 Other Stocks Under $2 Insiders Are Buying February 29, 2024 The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities What's Going On With Immunic Stock? January 05, 2024 Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 05, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 05, 2024 Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! Via InvestorPlace Immunic CSO hails "great" progress with MS program October 24, 2023 --News Direct-- Via News Direct Immunic CSO hails "great" progress with MS program October 24, 2023 Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof speaks to Thomas Warner at the Proactive London after returning from MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS meeting. She shares some... Via TheNewswire.com Immunic "super excited" about latest PMS trial data October 11, 2023 Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced encouraging interim data from its phase II CALLIPER trial... Via TheNewswire.com Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 10, 2023 Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 10, 2023 Via Benzinga Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate October 10, 2023 Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with Via Benzinga Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket October 10, 2023 Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 10, 2023 It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! Via InvestorPlace < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.